Replies to post #109080 on Cytodyn Inc (CYDY)

[Rockleo]

misiu143.. Yup..Very surprising..!!!

[drfreak]

I am practicing in a public/socialist system and can relate to her care.

The potential for oncology is potentially paradigm changing.

For the area that have not responded SABR - SRS - SBRT or low dose conformal for larger volumes could be given.

It would be an interesting research study to see how this would fit into the Oligometastatic Paradigm.

[bluefish1]

I believe with this trial, patients must also be under the care of an oncologist and receive chemo per the oncologist.

On hospice she would no longer be under the care of the oncologist, and so might not be able to continue leronlimab.

https://clinicaltrials.gov/ct2/show/NCT04313075?cond=leronlimab&draw=2&rank=4

Treatment of Physician's Choice (TPC) is defined as one of the following single-agent chemotherapy drugs administrated according to local practice: eribulin, gemcitabine, capecitabine, paclitaxel, nab-paclitaxel, vinorelbine, ixabepilone, or carboplatin.